Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024

Anke Kohlenberg¹, Olov Svartström¹, Petra Apfalter², Rainer Hartl², Pierre Bogaerts³, Te-Din Huang³, Katerina Chudejova⁴, Lucia Malisova^{5

6}, Jessica Eisfeld⁷, Mirco Sandfort⁸, Anette M Hammerum⁹, Louise Roer⁹, Kati Räisänen¹⁰, Laurent Dortet^{11

12}, Rémy A Bonnin^{11

12}, Ákos Tóth¹³, Kinga Tóth¹³, Christina Clarke¹⁴, Martin Cormican¹⁵, Algirdas Griškevičius¹⁶, Kirstin Khonyongwa¹⁷, Marie Meo¹⁷, Baiba Niedre-Otomere¹⁸, Reinis Vangravs¹⁸, Antoni Pa Hendrickx¹⁹, Daan W Notermans¹⁹, Ørjan Samuelsen²⁰, Manuela Caniça²¹, Vera Manageiro²¹, Vilhelm Müller²², Barbro Mäkitalo²², Urška Kramar²³, Mateja Pirs²⁴, Daniel Palm¹, Dominique L Monnet¹, Erik Alm¹, Marius Linkevicius¹

Affiliations

¹ European Centre for Disease Prevention and Control, Stockholm, Sweden.
² Austrian National Reference Centre for Antimicrobial Resistance, Ordensklinikum Linz Elisabethinen, Linz, Austria.
³ National Reference Centre for Antimicrobic-Resistant Gram-Negative Bacilli, Laboratory of Microbiology, CHU UCL Namur, Yvoir, Belgium.
⁴ Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia.
⁵ National Reference Laboratory for Antibiotics, National Institute of Public Health, Prague, Czechia.
⁶ Department of Microbiology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady and National Institute of Public Health, Prague, Czechia.
⁷ German National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
⁸ Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
⁹ National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
¹⁰ Finnish Institute for Health and Welfare, Helsinki, Finland.
¹¹ Associated French National Reference Centre for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicêtre, France.
¹² Team "Resist" UMR1184 "Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB)", INSERM, Université Paris-Saclay, CEA, IHU Prometheus Faculty of Medicine, Le Kremlin-Bicêtre, France.
¹³ National Centre for Public Health and Pharmacy, Budapest, Hungary.
¹⁴ Galway Reference Laboratory Service, Galway University Hospital, Galway, Ireland.
¹⁵ School of Medicine, University of Galway, Galway, Ireland.
¹⁶ National Public Health Surveillance Laboratory, Vilnius, Lithuania.
¹⁷ Service Bactériologie-Mycologie-Antibiorésistance-Hygiène Hospitalière, Département de Microbiologie, Laboratoire National de Santé, Dudelange, Luxembourg.
¹⁸ National Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases", Laboratory Service, Riga East University Hospital, Riga, Latvia.
¹⁹ Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
²⁰ Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
²¹ National Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
²² Public Health Agency of Sweden, Solna, Sweden.
²³ National Laboratory of Health, Environment and Food, Centre for Medical Microbiology, Maribor, Slovenia.
²⁴ Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

PMID: 39574387
PMCID: PMC11583312
DOI: 10.2807/1560-7917.ES.2024.29.47.2400727

Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024

Anke Kohlenberg et al. Euro Surveill. 2024 Nov.

. 2024 Nov;29(47):2400727.

doi: 10.2807/1560-7917.ES.2024.29.47.2400727.

Authors

Affiliations

¹ European Centre for Disease Prevention and Control, Stockholm, Sweden.
² Austrian National Reference Centre for Antimicrobial Resistance, Ordensklinikum Linz Elisabethinen, Linz, Austria.
³ National Reference Centre for Antimicrobic-Resistant Gram-Negative Bacilli, Laboratory of Microbiology, CHU UCL Namur, Yvoir, Belgium.
⁴ Department of Microbiology, Faculty of Medicine, University Hospital in Pilsen, Charles University, Pilsen, Czechia.
⁵ National Reference Laboratory for Antibiotics, National Institute of Public Health, Prague, Czechia.
⁶ Department of Microbiology, 3rd Faculty of Medicine, Charles University, University Hospital Kralovske Vinohrady and National Institute of Public Health, Prague, Czechia.
⁷ German National Reference Centre for Multidrug-resistant Gram-negative Bacteria, Department of Medical Microbiology, Ruhr-University Bochum, Bochum, Germany.
⁸ Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
⁹ National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
¹⁰ Finnish Institute for Health and Welfare, Helsinki, Finland.
¹¹ Associated French National Reference Centre for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicêtre, France.
¹² Team "Resist" UMR1184 "Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB)", INSERM, Université Paris-Saclay, CEA, IHU Prometheus Faculty of Medicine, Le Kremlin-Bicêtre, France.
¹³ National Centre for Public Health and Pharmacy, Budapest, Hungary.
¹⁴ Galway Reference Laboratory Service, Galway University Hospital, Galway, Ireland.
¹⁵ School of Medicine, University of Galway, Galway, Ireland.
¹⁶ National Public Health Surveillance Laboratory, Vilnius, Lithuania.
¹⁷ Service Bactériologie-Mycologie-Antibiorésistance-Hygiène Hospitalière, Département de Microbiologie, Laboratoire National de Santé, Dudelange, Luxembourg.
¹⁸ National Microbiology Reference Laboratory of Latvia, Laboratory "Latvian Centre of Infectious Diseases", Laboratory Service, Riga East University Hospital, Riga, Latvia.
¹⁹ Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
²⁰ Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
²¹ National Reference Laboratory of Antibiotic Resistances and Healthcare Associated Infections, Department of Infectious Diseases, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
²² Public Health Agency of Sweden, Solna, Sweden.
²³ National Laboratory of Health, Environment and Food, Centre for Medical Microbiology, Maribor, Slovenia.
²⁴ Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

PMID: 39574387
PMCID: PMC11583312
DOI: 10.2807/1560-7917.ES.2024.29.47.2400727

Abstract

Analysis of 594 isolates of Escherichia coli sequence type (ST)131 and its single locus variants carrying carbapenemase genes from 17 European Union/European Economic Area countries revealed acquisition of 18 carbapenemase variants, mainly in ST131 clades A and C. Most frequent were bla _OXA-244 (n = 230) and bla _OXA-48 (n = 224), detected in 14 and 12 countries, respectively. Isolates carrying bla _OXA-244 have increased rapidly since 2021. The increasing detection of carbapenemase genes in the E. coli high-risk lineage ST131 is a public health concern.

Keywords: Carbapenem-resistant Enterobacterales; Escherichia coli; antibiotics; antimicrobial resistance; carbapenemase; cross-border spread; surveillance; whole genome sequencing.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

**Figure 1**
Number of *Escherichia coli* ST131 isolates, including its single locus variants^a, carrying carbapenemase genes, by year, EU/EEA, 2012–2023^b (n = 535)

**Figure 2**
Phylogenetic tree of *Escherichia coli* ST131 isolates, including its single locus variants included in the genomic relatedness analysis, EU/EEA and outside, 2005–2024 (n = 691)

See this image and copyright information in PMC

References

1. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55. 10.1016/S0140-6736(21)02724-0 - DOI - PMC - PubMed
1. Mathers AJ, Peirano G, Pitout JD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28(3):565-91. 10.1128/CMR.00116-14 - DOI - PMC - PubMed
1. Welker S, Boutin S, Miethke T, Heeg K, Nurjadi D. Emergence of carbapenem-resistant ST131 Escherichia coli carrying bla OXA-244 in Germany, 2019 to 2020. Euro Surveill. 2020;25(46):2001815. 10.2807/1560-7917.ES.2020.25.46.2001815 - DOI - PMC - PubMed
1. Piazza A, Corbella M, Mattioni Marchetti V, Merla C, Mileto I, Kuka A, et al. Clinical isolates of ST131 blaOXA-244-positive Escherichia coli, Italy, December 2022 to July 2023. Euro Surveill. 2024;29(8):2400073. 10.2807/1560-7917.ES.2024.29.8.2400073 - DOI - PMC - PubMed
1. Patiño-Navarrete R, Rosinski-Chupin I, Cabanel N, Zongo PD, Héry M, Oueslati S, et al. Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015. mSystems. 2022;7(1):e0116921. 10.1128/msystems.01169-21 - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- PubMed Central
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024

Affiliations

Emergence of Escherichia coli ST131 carrying carbapenemase genes, European Union/European Economic Area, August 2012 to May 2024

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

References

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical